Wal-Mart is raising minimum wage to $11 and dishing out a one-time bonus for employees, citing the Trump Tax Reform plan. Karen Short, Managing Director at Barclays, was with us to discuss the ramifications of the decision. Short estimates that Wal-Mart could generate $4 billion in incremental free cash flow due to the tax reform, and adds that the wage hike is just of portion of the allocation. The analyst says that the "strong will get stronger" and other retailers will have to follow Wal-Mart's lead. Tax reform narrows the advantage Amazon has over traditional retailers such as Wal-Mart, says Short. She says Wal-Mart has an advantage over Amazon because it is the largest grocer with low prices. Short also adds that the stigma surrounding Wal-Mart products has dissipated and is no longer a "turnoff" to millennials because the products have gotten better.

Share:
More In Business
Poll: More Americans think companies benefit from legal immigration
A new poll finds U.S. adults are more likely than they were a year ago to think immigrants in the country legally benefit the economy. That comes as President Donald Trump's administration imposes new restrictions targeting legal pathways into the country. The Associated Press-NORC Center for Public Affairs Research survey finds Americans are more likely than they were in March 2024 to say it’s a “major benefit” that people who come to the U.S. legally contribute to the economy and help American companies get the expertise of skilled workers. At the same time, perceptions of illegal immigration haven’t shifted meaningfully. Americans still see fewer benefits from people who come to the U.S. illegally.
Tylenol maker rebounds a day after unfounded claims about its safety
Shares of Tylenol maker Kenvue are bouncing back sharply before the opening bell a day after President Donald Trump promoted unproven and in some cases discredited ties between Tylenol, vaccines and autism. Trump told pregnant women not to use the painkiller around a dozen times during the White House news conference Monday. The drugmaker tumbled 7.5%. Shares have regained most of those losses early Tuesday in premarket trading.
Load More